Eurizon Capital SGR S.p.A. Makes New Investment in Revvity Inc. $RVTY

Eurizon Capital SGR S.p.A. bought a new position in Revvity Inc. (NYSE:RVTY) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 79,495 shares of the company’s stock, valued at approximately $7,691,000. Eurizon Capital SGR S.p.A. owned approximately 0.07% of Revvity at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of RVTY. EdgePoint Investment Group Inc. grew its holdings in shares of Revvity by 26.3% in the third quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company’s stock worth $751,536,000 after acquiring an additional 1,784,620 shares during the period. Invesco Ltd. grew its holdings in shares of Revvity by 15.7% in the third quarter. Invesco Ltd. now owns 2,553,515 shares of the company’s stock worth $223,816,000 after acquiring an additional 346,313 shares during the period. UBS Group AG grew its holdings in shares of Revvity by 22.3% in the third quarter. UBS Group AG now owns 2,179,505 shares of the company’s stock worth $191,034,000 after acquiring an additional 397,160 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Revvity by 39.0% in the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after acquiring an additional 596,436 shares during the period. Finally, Allspring Global Investments Holdings LLC grew its holdings in shares of Revvity by 127.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,751,612 shares of the company’s stock worth $171,921,000 after acquiring an additional 980,142 shares during the period. Institutional investors own 86.65% of the company’s stock.

Revvity Price Performance

Shares of Revvity stock opened at $104.88 on Monday. The stock’s 50-day simple moving average is $92.03 and its 200-day simple moving average is $97.27. Revvity Inc. has a 52 week low of $81.22 and a 52 week high of $118.30. The company has a market capitalization of $11.70 billion, a price-to-earnings ratio of 50.18, a PEG ratio of 2.25 and a beta of 1.11. The company has a quick ratio of 1.41, a current ratio of 1.72 and a debt-to-equity ratio of 0.37.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.02 by $0.04. Revvity had a return on equity of 8.00% and a net margin of 8.26%.The business had revenue of $711.12 million for the quarter, compared to the consensus estimate of $704.07 million. During the same period in the previous year, the business earned $1.01 earnings per share. The business’s revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. As a group, analysts expect that Revvity Inc. will post 5.32 earnings per share for the current fiscal year.

Revvity Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Friday, July 17th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th. Revvity’s payout ratio is presently 13.40%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. TD Cowen boosted their price target on Revvity from $115.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Barclays boosted their price target on Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a report on Thursday, May 7th. The Goldman Sachs Group cut their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a report on Tuesday, April 14th. Wells Fargo & Company boosted their price target on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a report on Tuesday, February 3rd. Finally, Weiss Ratings lowered Revvity from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 13th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $107.73.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.